Literature DB >> 33925465

Conformational and Immunogenicity Studies of the Shigella flexneri Serogroup 6 O-Antigen: The Effect of O-Acetylation.

Nicole Inge Richardson1, Neil Ravenscroft1, Vanessa Arato2, Davide Oldrini2, Francesca Micoli2, Michelle M Kuttel3.   

Abstract

The pathogenic bacterium Shigella is a leading cause of diarrheal disease and mortality, disproportionately affecting young children in low-income countries. The increasing prevalence of antibiotic resistance in Shigella necessitates an effective vaccine, for which the bacterial lipopolysaccharide O-antigen is the primary target. S. flexneri serotype 6 has been proposed as a multivalent vaccine component to ensure broad protection against Shigella. We have previously explored the conformations of S. flexneri O-antigens from serogroups Y, 2, 3, and 5 that share a common saccharide backbone (serotype Y). Here we consider serogroup 6, which is of particular interest because of an altered backbone repeat unit with non-stoichiometric O-acetylation, the antigenic and immunogenic importance of which have yet to be established. Our simulations show significant conformational changes in serogroup 6 relative to the serotype Y backbone. We further find that O-acetylation has little effect on conformation and hence may not be essential for the antigenicity of serotype 6. This is corroborated by an in vivo study in mice, using Generalized Modules for Membrane Antigens (GMMA) as O-antigen delivery systems, that shows that O-acetylation does not have an impact on the immune response elicited by the S. flexneri serotype 6 O-antigen.

Entities:  

Keywords:  GMMA; O-acetylation; O-antigen; Shigella flexneri; conformation; molecular modeling

Year:  2021        PMID: 33925465     DOI: 10.3390/vaccines9050432

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  38 in total

1.  Quantifying uncertainty and sampling quality in biomolecular simulations.

Authors:  Alan Grossfield; Daniel M Zuckerman
Journal:  Annu Rep Comput Chem       Date:  2009-01-01

2.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

3.  Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation.

Authors:  Jason Hlozek; Michelle M Kuttel; Neil Ravenscroft
Journal:  Carbohydr Res       Date:  2018-06-22       Impact factor: 2.104

4.  Effects of Glucosylation and O-Acetylation on the Conformation of Shigella flexneri Serogroup 2 O-Antigen Vaccine Targets.

Authors:  Jason Hlozek; Neil Ravenscroft; Michelle M Kuttel
Journal:  J Phys Chem B       Date:  2020-03-31       Impact factor: 2.991

5.  Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity.

Authors:  Charles Gauthier; Pierre Chassagne; François-Xavier Theillet; Catherine Guerreiro; Françoise Thouron; Farida Nato; Muriel Delepierre; Philippe J Sansonetti; Armelle Phalipon; Laurence A Mulard
Journal:  Org Biomol Chem       Date:  2014-06-28       Impact factor: 3.876

6.  Draft genomes of Shigella strains used by the STOPENTERICS consortium.

Authors:  Omar Rossi; Kate S Baker; Armelle Phalipon; François-Xavier Weill; Francesco Citiulo; Philippe Sansonetti; Christiane Gerke; Nicholas R Thomson
Journal:  Gut Pathog       Date:  2015-06-04       Impact factor: 4.181

7.  Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against Shigella.

Authors:  Omar Rossi; Eleonora Molesti; Allan Saul; Carlo Giannelli; Francesca Micoli; Francesca Necchi
Journal:  High Throughput       Date:  2020-06-08

Review 8.  Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human.

Authors:  Louis-Antoine Barel; Laurence A Mulard
Journal:  Hum Vaccin Immunother       Date:  2019       Impact factor: 3.452

9.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

10.  Molecular Modeling of the Shigella flexneri Serogroup 3 and 5 O-Antigens and Conformational Relationships for a Vaccine Containing Serotypes 2a and 3a.

Authors:  Jason Hlozek; Sara Owen; Neil Ravenscroft; Michelle M Kuttel
Journal:  Vaccines (Basel)       Date:  2020-11-02
View more
  5 in total

1.  Increasing the High Throughput of a Luminescence-Based Serum Bactericidal Assay (L-SBA).

Authors:  Maria Grazia Aruta; Martina Carducci; Francesca Micoli; Francesca Necchi; Omar Rossi
Journal:  BioTech (Basel)       Date:  2021-09-18

Review 2.  GMMA-Based Vaccines: The Known and The Unknown.

Authors:  Francesca Mancini; Francesca Micoli; Francesca Necchi; Mariagrazia Pizza; Francesco Berlanda Scorza; Omar Rossi
Journal:  Front Immunol       Date:  2021-08-03       Impact factor: 7.561

3.  Comparison and Optimization of Quantification Methods for Shigella flexneri Serotype 6 O-antigen Containing Galacturonic Acid and Methyl-Pentose.

Authors:  Maria Michelina Raso; Oscar Vassallo; Francesca Micoli; Carlo Giannelli
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

4.  Modeling of pneumococcal serogroup 10 capsular polysaccharide molecular conformations provides insight into epitopes and observed cross-reactivity.

Authors:  Nicole I Richardson; Michelle M Kuttel; Neil Ravenscroft
Journal:  Front Mol Biosci       Date:  2022-08-08

5.  Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice.

Authors:  Arun Naini; Max Peter Bartetzko; Someswara Rao Sanapala; Felix Broecker; Victoria Wirtz; Marilda P Lisboa; Sharavathi G Parameswarappa; Daniel Knopp; Jessica Przygodda; Matthias Hakelberg; Rosalind Pan; Axay Patel; Laurent Chorro; Arthur Illenberger; Christopher Ponce; Srinivas Kodali; Jacqueline Lypowy; Annaliesa S Anderson; Robert G K Donald; Arne von Bonin; Claney L Pereira
Journal:  JACS Au       Date:  2022-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.